NMRA Dividend History & Analysis | N/A Yield
NMRA has a dividend yield of N/A and paid N/A per share in the last 12M. Complete payout history, full analyses and peer comparison.
Top Dividend Payers in Pharmaceuticals
| Symbol | Market Cap (USD) | Dividend Yield TTM | Yield on Cost (purchase 5y ago) |
|---|---|---|---|
| SIGA | 593 M | 7.32% | 11.6% |
| PFE | 138,102 M | 8.68% | 7.77% |
| OGN | 1,755 M | 8.94% | 2.20% |
| BMY | 93,773 M | 5.39% | 4.73% |
| GS71 | 94,055 M | 4.07% | 6.62% |
| Symbol | Market Cap (USD) | Growth Rate (CAGR) | Payout Consistency |
|---|---|---|---|
| RPRX | 21,892 M | 29.4% | 100% |
| ZTS | 63,858 M | 21.2% | 100% |
| LLY | 772,276 M | 15.1% | 99.5% |
| SIGA | 593 M | 15.5% | 98.8% |
| RDY | 11,250 M | 28.0% | 87.3% |
Similar Stocks with Attractive Dividends - Compare NMRA Dividends with its Peer-Group
7.32% Yield
3.93% Yield
3.44% Yield
4.51% Yield
3.43% Yield
3.22% Yield
NMRA Dividend History: as of November 2025
No dividends paid yet.NMRA Dividend FAQ
Neumora Therapeutics (NASDAQ: NMRA) is a clinical-stage biopharma focused on oral small-molecule therapies for central-nervous-system (CNS) disorders, including major depressive disorder (MDD), dementia-related agitation, schizophrenia, amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and other neurodegenerative conditions. Its lead asset, navacaprant (NMRA-140), is a once-daily kappa-opioid receptor antagonist currently in a pivotal Phase 3 trial for MDD, while NMRA-511 is in Phase 1 for agitation in Alzheimer’s disease.
What is the Dividend Yield of NMRA?
As of November 2025, NMRA`s dividend yield is %. This is calculated by dividing the trailing 12-month dividend rate (TTM rate) of - by the current share price of 3.01.Does NMRA pay a dividend?
As of November 2025 NMRA does not pay a dividend.How often does NMRA pay dividends?
Over the last 12 months, NMRA has issued dividend payments.Will NMRA pay dividends in 2025?
The next Ex-Dividend date for Neumora Therapeutics (NMRA) is currently unknown.What is the next Ex-Dividend Date for NMRA?
The next Ex-Dividend date for Neumora Therapeutics (NMRA) is currently unknown. We automatically update the next Ex-Dividend date when it is announced.What is the Dividend Growth of NMRA?
NMRA's average dividend growth rate over the past 5 years is -% per year.
What is the Yield on Cost of NMRA?
NMRA's 5-Year Yield on Cost is -%. If you bought NMRA's shares at 17.00 five years ago, your current annual dividend income (- per share, trailing 12 months) equals -% of your original purchase price.What is the Payout Consistency of NMRA?
NMRA Payout Consistency is 0.0%.
The payout consistency is a proprietary measure of how consistently a company has paid dividends over its lifetime and blends growth rate, number of dividend payments, interruptions or lowering dividends into one number.
Does NMRA have a good Dividend Yield?
NMRA`s % Dividend Yield is considered as unknown.What is the Dividend Payout Ratio of NMRA?
The Dividend Payout Ratio of NMRA is unknown.What is the Dividend Rating of NMRA?
NMRA`s Overall Dividend Rating is (unknown). Ratings surpassing 65% are regarded as acceptable, exceeding 75% are favorable and surpassing 85% are strong.Key Metric Definitions
- Dividend Yield: Annual dividend per share divided by current share price.
- Dividend Growth Rate: Compound annual growth rate of annual dividend per share over the last 5 years.
- Payout Ratio: Percentage of earnings paid as dividends (TTM).
- Payout Consistency: % of eligible periods with uninterrupted or increased dividends, measured over the entire lifetime of the stock or fund.
- Payout Frequency: Number of dividends paid in the last 12m (TTM).
- Overall Dividend Rating: Proprietary composite score, quantified on a scale from 0 to +100. Ratings surpassing 70 are regarded as favorable, while those exceeding 85 are strong.
- Total Return: Price appreciation plus dividends over specified period.
- Market Cap: Figures are in millions of the corresponding currency.
Last update: 2025-10-17 04:43